简介：
Overview
This article describes a method for generating a doxorubicin-induced cardiomyopathy model in adult zebrafish (Danio rerio). It outlines two techniques for intraperitoneal injection and discusses strategies to minimize variability among experimental groups.
Key Study Components
Area of Science
- Neuroscience
- Cardiology
- Pharmacology
Background
- Doxorubicin is a chemotherapeutic agent known to induce cardiotoxicity.
- Zebrafish are a valuable model organism for studying cardiac function and drug effects.
- Understanding drug efficacy and toxicity is crucial for developing safer therapeutic strategies.
- Variability in experimental results can arise from differences in injection techniques.
Purpose of Study
- To establish a reliable zebrafish model for studying doxorubicin-induced cardiomyopathy.
- To compare the efficacy of two intraperitoneal injection methods.
- To assess the impact of doxorubicin on cardiac function over time.
Methods Used
- Preparation of doxorubicin stock solution and quality control testing of zebrafish embryos.
- Intraperitoneal injection techniques for administering doxorubicin.
- Monitoring of fish for signs of toxicity and cardiac dysfunction.
- Use of transgenic zebrafish to visualize cardiac function under a fluorescent microscope.
Main Results
- The alternative lateral injection method reduced leakage and improved survival rates compared to the classic method.
- At a lower dose of 20 mg/kg, fish maintained chronic observation with minimal mortality.
- Cardiac dysfunction was observed starting four weeks post-injection.
- Both injection techniques allowed for efficient administration of doxorubicin to multiple fish.
Conclusions
- The lateral injection method is recommended for better outcomes in zebrafish models of cardiomyopathy.
- Long-term monitoring is essential to assess drug effects on cardiac function.
- This model can facilitate high-throughput screening for cardiotoxicity and therapeutic interventions.
What is the significance of using zebrafish in this study?
Zebrafish are a powerful model for studying cardiac function due to their transparent embryos and rapid development.
How does doxorubicin affect zebrafish?
Doxorubicin can induce cardiomyopathy, allowing researchers to study its effects on heart function and toxicity.
What are the advantages of the lateral injection method?
The lateral injection method minimizes leakage of the drug and improves survival rates of the fish post-injection.
How is cardiac function assessed in this model?
Cardiac function is assessed using transgenic zebrafish that express fluorescent markers, allowing visualization of heart activity.
What precautions should be taken during the injection process?
Ensure proper anesthesia and technique to minimize stress and injury to the fish during injection.
What is the recommended dose of doxorubicin for this model?
A dose of 20 mg/kg is recommended for chronic observation with minimal mortality.
How can this model be used in drug screening?
This zebrafish model can be used for high-throughput screening of potential cardioprotective agents and assessing drug toxicity.
繁體中文
